Drug Profile
Research programme: protein therapeutics - Affibody
Alternative Names: CAIX - Affibody; HER3 - AffibodyLatest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Affibody
- Class Proteins
- Mechanism of Action Carbonic anhydrase inhibitors; ERBB-3 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Breast cancer; Cancer
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for research development in Breast-cancer in Sweden (SC)
- 04 Nov 2017 No recent reports of development identified for research development in Cancer in Sweden (SC)
- 23 Apr 2012 Research is ongoing in Sweden